AVR 1.29% $18.31 anteris technologies ltd

News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-556

  1. 3,543 Posts.
    lightbulb Created with Sketch. 150

    I realise what you're saying, but this is only one children's hospital in Poland, are there others and what about the other hospitals that do adult operations.
    I would imagine that a lot of the Cardiac surgeons, would go to different conferences within in their country to hear and see leading surgeons doing operations with new techniques/ products, to show the benefits of using them.
    I know my wife has scrubed for a leading NZ orthopedic surgeon doing this a number of times.
    There's approx 38 million people in Poland, so there'spossibly quite a few people that would do well by using one of the CardioCel range.

    The more they can promote CC ADAPT, the better and one of the best advertisements, is continued praise for Admedus's products.
    Looking forward to the next update to see if the tide has turned.

    Regards
    Dabru
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$18.31
Change
-0.240(1.29%)
Mkt cap ! $351.9M
Open High Low Value Volume
$18.80 $19.15 $18.20 $159.7K 8.611K

Buyers (Bids)

No. Vol. Price($)
1 73 $18.31
 

Sellers (Offers)

Price($) Vol. No.
$18.33 90 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.